Sartorius Appoints Internationally Experienced Laboratory Manager
News Jan 31, 2014
Effective April 1, 2014, Michael Melingo will head marketing, sales and services of the Lab Products & Services Division at Sartorius. He will therefore succeed Dominique Baly, who will retire from the company as planned after reaching retirement age.
Michael Melingo will report to CEO and Executive Board Chairman Dr. Joachim Kreuzburg and be a member of the Group Executive Committee, the highest operational management level of the Sartorius Group.
Michael Melingo, who brings more than 30 years of experience in the industry as a sales and marketing executive, will be joining Sartorius from Metrohm, the Swiss manufacturer of analytical instruments, where he was CEO of its U.S. subsidiary.
Before that, he had worked for Baxter, Bio-Rad, Millipore and Waters in Europe and Asia. Michael Melingo is of Austrian nationality and a bioengineer who specializes in biochemistry and food technology.
“With Michael, we have found an exceptionally experienced manager to join our team, who has successfully managed international laboratory businesses. In his new role at Sartorius, he will focus on further developing the global sales, marketing and service organization of our laboratory division business and strengthen its strategic positioning,” said Sartorius CEO and Executive Board Chairman Joachim Kreuzburg.
Fossilized Algae Hold Promise for Improved Food Safety TestingNews
Researchers, exploiting thin-layer chromatography and surface-enhanced Raman scattering, have used fossilized remains of algae to take a key step toward being able to more sensitively detect harmful contaminants in food.READ MORE
Rapid Removal of Arsenic From Drinking Water...By Moss!News
A moss capable of removing arsenic from contaminated water has been discovered by researchers. And it happens quickly – in just one hour, the arsenic level is so low that the water is no longer harmful for people to drink.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018